Currently, he is the executive director of CSCO, a member of CSCO Expert Committee for Vascular Targeted Therapy, a young member of China Anti-Cancer Association Breast Cancer Professional Committee, an executive director of Heilongjiang Medical Association, the fourth director of Heilongjiang Anti-Cancer Association, a member of Heilongjiang Breast Cancer Professional Committee, and a member of Heilongjiang and Harbin Medical Accident Identification Expert Database. Editorial Committee of Chinese Journal of Oncology and Standing Editorial Committee of Chinese Journal of Lung Cancer. He presided over 9 national, provincial and municipal projects and won 8 scientific and technological achievement awards. Published 53 academic papers in national and provincial magazines, 6 of which were included in SCI.

Engaged in clinical oncology for nearly 20 years, studying in internal medicine of Japan Medical University 1 year. During my doctoral and postdoctoral studies, I conducted in-depth research on the mechanism of drug resistance of chemotherapy drugs. He is good at chemotherapy, endocrine therapy, biological immunity and targeted therapy for breast cancer.